David A. Boothman

Also affiliated with Indiana Cancer Consortium, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors”.

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Cancer Cell(2016)10.1016/j.ccell.2016.11.006

N/A

0.735DataRank · unranked

133 citations

Edward A. Motea, Zachary R. Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti +19 more

Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors

Cell Systems(2021)10.1016/j.cels.2020.12.001

N/A

0.624DataRank · unranked

63 citations

Tom E. Forshaw, David A. Boothman, Cristina M. Furdui, Melissa L. Kemp, Joshua E. Lewis

MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.536377

N/A

0DataRank · unranked

12 citations

Naveen Singh, Joshua E. Lewis, Allen W. Tsang, David A. Boothman, Melissa L. Kemp +2 more

NQO1-Bioactivatable Therapeutics as Radiosensitizers for Cancer Treatment

IntechOpen eBooks(2020)10.5772/intechopen.90205

N/A

0DataRank · unranked

1 citations

Edward A. Motea, Xiumei Huang, Colton L. Starcher, Jayne M. Silver, I‐Ju Yeh +6 more

Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone

Redox Biology(2020)10.1016/j.redox.2020.101440

N/A

0DataRank · unranked

46 citations

Nicolas Prieto-Farigua, Aimee Falzone, Cody Elkins, David A. Boothman, Eric B. Haura +2 more

Data from Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS Mutations

(2023)10.1158/0008-5472.c.6499220.v1

N/A

0DataRank · unranked

0 citations

Erik A. Bey, Andrea Rabellino, Katja Schuster, Michael S. Maira, Adi F. Gazdar +4 more

Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.07.029694

N/A

0DataRank · unranked

4 citations

Tom E. Forshaw, David A. Boothman, Cristina M. Furdui, Melissa L. Kemp, Joshua E. Lewis

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.01575

N/A

0DataRank · unranked

20 citations

S. Louise Pay, Naveen Singh, I‐Ju Yeh, Snehal B. Bhandare, Xiaolin Su +5 more